- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04:53 | Ihre wichtigsten Termine: Spannende Zahlen von: Sony, Moderna, AbbVie, Eaton, ExxonMobil, Linde und Puma! | 1.142 | wallstreetONLINE | © Foto: picture alliance / CFOTO | CFOTOGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| Do | DBV Technologies S.A.: DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq | 1.085 | GlobeNewswire (Europe) | Châtillon, France, July 30, 2026
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
DBV Technologies (Euronext: DBV - ISIN:... ► Artikel lesen | |
| 05:47 | Novo Nordisk und Eli Lilly zeigen, wie Blockbuster entstehen - warum Biotech-Unternehmen mit mehreren Wachstumstreibern plötzlich interessanter werden | Small- & Micro Cap Investment | |||
| 00:02 | Hemostemix Inc.: Hemostemix Closes Second Tranche of Private Placement and Obtains Extension to August 14, 2026 | 493 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 30, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it has closed the second tranche... ► Artikel lesen | |
| Do | Myriad Genetics, Inc.: Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability | 490 | GlobeNewswire (Europe) | Highlights Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% decrease in average revenue per test year-over-year. The company is... ► Artikel lesen | |
| 17:12 | Weekly Buzz: Cipla, Viatris Win FDA Nod; Boston Scientific Cuts Jobs; argenx Snaps Up Forte Biosciences; Johnson & Johnson, GSK Strike Deals | 475 | AFX News | NEW BRUNSWICK (dpa-AFX) - The healthcare sector delivered another eventful week, marked by major regulatory approvals, strategic partnerships, acquisitions, restructuring initiatives and significant... ► Artikel lesen | |
| Do | EQS-News: ABIVAX: Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod | 422 | EQS Group (EN) | EQS-News: ABIVAX
/ Key word(s): Regulatory Admission
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
30.07.2026 / 22:05 CET/CEST
The issuer... ► Artikel lesen | |
| Do | Stryker Corp. Bottom Line Rises In Q2 | 416 | AFX News | WASHINGTON (dpa-AFX) - Stryker Corp. (SYK) revealed a profit for its second quarter that Increases, from the same period last yearThe company's bottom line came in at $1.276 billion, or $3.30... ► Artikel lesen | |
| Do | Karyopharm Therapeutics Inc.: Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer | 407 | PR Newswire | - The Trial Did Not Meet the Primary Endpoint of Progression-Free Survival (PFS) -
- A Trend Favoring the Selinexor Arm was Observed with a 5.3 Month Improvement... ► Artikel lesen | |
| 14:48 | Morning Market Movers: Replimune Group, BioAge Labs, T3 Defense, AXT, Inc. See Big Swings | 386 | AFX News | BEIJING (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| Do | POXEL SA: Poxel Publishes Its Turnover for the Second Quarter of 2026 and Announces the Postponement of the Publication of Its 2025 Financial Statements | 356 | Business Wire | Consolidated net sales of TWYMEEGin Japan for the2nd quarter of 2026 reached 2.9 billion yen (15.5 million euros1), up 32 per cent compared with the 2nd quarter of 2025. Consolidated net... ► Artikel lesen | |
| Do | Neurocrine Biosciences Inc Q2 Profit Climbs | 348 | AFX News | WASHINGTON (dpa-AFX) - Neurocrine Biosciences Inc (NBIX) released earnings for its second quarter that Increases, from last yearThe company's bottom line totaled $144.4 million, or $1.39 per... ► Artikel lesen | |
| 15:45 | Moderna dämpft die Kosten, kämpft aber weiter mit hohen Verlusten | 345 | 4investors | Moderna hat im zweiten Quartal 2026 einen Umsatz von 145 Millionen US-Dollar erzielt, nach 142 Millionen US-Dollar im Vorjahresquartal. Rückläufige COVID-Impfstoffverkäufe in den USA und Südamerika... ► Artikel lesen | |
| Do | Illumina Inc. Profit Retreats In Q2 | 343 | AFX News | SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) revealed earnings for second quarter that Drops, from the same period last yearThe company's earnings came in at $207 million, or $1.35 per share.... ► Artikel lesen | |
| 13:06 | Tenax Therapeutics, Inc.: Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | 334 | GlobeNewswire (Europe) | Company expects to report topline data from Phase 3 LEVEL clinical trial in August 2026 CHAPEL HILL, N.C., July 31, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) ("Tenax" or "Tenax... ► Artikel lesen |
1 2 3 Weiter >>
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| NOVOGENIA | 6,200 | 0,56 | +9,03 % | 2,45 | ||
| PHILOGEN | 22,650 | 1,40 | +6,18 % | |||
| CIBUS | 1,900 | 0,10 | +5,19 % | 0,24 | ||
| RECORDATI | 52,00 | 1,34 | +2,58 % | 0,76 | ||
| PHARMAMAR | 79,15 | 2,00 | +2,53 % | 1,00 | ||
| REIG JOFRE | 2,600 | 0,04 | +1,67 % | 0,02 | ||
| BIOMERIEUX | 69,75 | 0,98 | +1,41 % | 0,98 | ||
| SARTORIUS STEDIM BIOTECH SA ADR | 16,700 | 0,21 | +1,25 % | 0,05 | ||
| SARTORIUS STEDIM BIOTECH | 166,60 | 0,69 | +0,41 % | 0,69 | ||
| AMGEN | 333,90 | 0,00 | 0,00 % |
1 2 3 4 5 Weiter >>
Mi
VANCOUVER, BC / ACCESS Newswire / July 29, 2026 / NiobiumX Mining Inc. (CSE:NIOX)(OTCQB:AFXLF)(FSE:O5K) ("NiobiumX" or the "Company"), formerly Arctic Fox Lithium Corp., is pleased to announce that its common shares commenced trading on the Canadian...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
23.07.
Cash position of €9.7 million as of June 30, 2026
Shareholder loan agreement signed with Vester Finance in April 2026, securing a cash runway until the beginning of Q2 2027
BioChaperone feasibility studies with positive results...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
18.07.
BASEL (dpa-AFX) - This week, the healthcare sector saw multiple U.S FDA and European Commission approvals, strategic licensing and M&A activity, as well as pivotal clinical trial readouts and regulatory setbacks.Positive data readouts spanned...
► Artikel lesen
► Artikel lesen
21.07.
Company receives positive pre-IND feedback from US FDA for CLD-401, indicating agreement on its current development strategy as it advances towards a first-in-human study; targeting dosing first patient in Q1 2027 Company demonstrated the versatility...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
Sa
Aktien - spannende Woche. Während der Iran-US-Konflikt weitergeht, sich hochzuschaukeln droht, steigen die Rohstoffpreise - Öl wieder über 100,00 USD. Und so wird ein positives Zinsszenario immer unwahrscheinlicher - Aktienmärkte preisen es ein. So...
► Artikel lesen
► Artikel lesen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.